Oncopeptides is a clinical development pharmaceutical company focused on bringing anti-cancer research as treatments for the benefit of patients.

Pharmaceutical

Oncopeptides

Sofia Heigis ️

Ulrica Westermark

Stefan Svensson Gelius

Ellen Santangelo

Lotta Larsson

Henrik Bergentoft

Lisa Swedel

Lisa Andersson

Stefan Norin

Karolina Vilval

Eva Nordström

Anders Martin-Löf

Per Wold-Olsen

Jonas Brambeck

Brian Stuglik

Per Samuelsson

Jennifer Jackson

Cecilia Daun Wennborg

The Research and Development team at Oncopeptides AB is dedicated to advancing anti-cancer therapies through innovative research and rigorous clinical testing. Comprising experts in various scientific disciplines, the team collaborates to develop, optimize, and translate novel compounds into effective treatments, ensuring that their findings translate into real-world benefits for patients battling cancer.

Research and Development

The Corporate Governance team at Oncopeptides AB is responsible for ensuring compliance with regulatory requirements and best practices in corporate governance. This team, comprising key executives and board members, focuses on strategic decision-making, risk management, and fostering transparent communication with stakeholders, all while supporting the company's mission to advance innovative anti-cancer treatments.

Corporate Governance

This department engages with healthcare professionals to communicate scientific information and support the therapeutic areas of the organization.

Medical Affairs

The Medical Affairs and Clinical Operations team at Oncopeptides AB is responsible for overseeing the design and execution of clinical trials, ensuring the scientific integrity of research, and facilitating communication between clinical data and regulatory bodies. This team collaborates with medical professionals to provide crucial insights into anti-cancer products, supports regulatory submissions, and ensures the efficient supply of investigational drugs for clinical studies, all aimed at advancing patient care in oncology.

Medical Affairs and Clinical Operations

The Financial and Investor Relations team at Oncopeptides AB is responsible for managing the company's financial strategies and communication with investors. They ensure accurate financial reporting, oversee accounting practices, and cultivate relationships with stakeholders to effectively convey the company's progress and potential in anti-cancer research. Through transparent financial disclosures, the team aims to build investor confidence and support for the company's clinical advancements.

Financial and Investor Relations

This department focuses on managing key client relationships and driving business growth in the oncology sector.

Oncopeptides

Org chart

Board & advisors

Teams

Research and Development

Corporate Governance

Medical Affairs

Medical Affairs and Clinical Operations

Financial and Investor Relations

Account Management

Offices

Oncopeptides

Org chart

Board & advisors

Teams

Research and Development

Corporate Governance

Medical Affairs

Medical Affairs and Clinical Operations

Financial and Investor Relations

Account Management

Offices

Related companies